2001 Stock Overview
Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in China.
Zhejiang NHU Company Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥19.76|
|52 Week High||CN¥31.52|
|52 Week Low||CN¥17.50|
|1 Month Change||1.65%|
|3 Month Change||-19.90%|
|1 Year Change||-17.47%|
|3 Year Change||25.79%|
|5 Year Change||22.99%|
|Change since IPO||1,595.84%|
Recent News & Updates
|2001||CN Pharmaceuticals||CN Market|
Return vs Industry: 002001 underperformed the CN Pharmaceuticals industry which returned -9.6% over the past year.
Return vs Market: 002001 underperformed the CN Market which returned -16.1% over the past year.
|2001 Average Weekly Movement||5.1%|
|Pharmaceuticals Industry Average Movement||6.5%|
|Market Average Movement||5.8%|
|10% most volatile stocks in CN Market||9.0%|
|10% least volatile stocks in CN Market||3.8%|
Stable Share Price: 002001 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 002001's weekly volatility (5%) has been stable over the past year.
About the Company
|1999||10,805||Bai Shan Hu||https://www.cnhu.com|
Zhejiang NHU Company Ltd. engages in the production and sale of nutritional products, flavor and fragrances, new polymer materials, and APIs in China. The company offers nutrition products, such as vitamin E, vitamin A, vitamin C, DL-Methionine, vitamin D3, biotin, coenzyme Q10, carotenoids, etc. for used in feed additives, and nutrition supplements of food, beverages, health food, etc.; and flavor and fragrance products comprising linalool series, citral series, cis-3-hexenol series, methyl dihydrojasmonate, raspberry ketone, and ligustral for used in personal care, cosmetic, and food fields. It also provides polymer materials, including polyphenylene sulfide and poly phthalamide for used in electronic and electrical, automotive, environmental protection, etc.; and APIs, such as moxifloxacin hydrochloride, vitamin A, vitamin D3, etc. to use as active pharmaceutical ingredients for processing and producing pharmaceutical preparations.
Zhejiang NHU Company Ltd. Fundamentals Summary
|2001 fundamental statistics|
Is 2001 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|2001 income statement (TTM)|
|Cost of Revenue||CN¥9.97b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||1.28|
|Net Profit Margin||24.50%|
How did 2001 perform over the long term?See historical performance and comparison